You start with 0.6 milligrams for the first week, then increase to 1.2 milligrams
Retinal Disorders in Patients with Type 2 Diabetes In a trial of adult patients with type 2 diabetes and BMI greater than or equal to 27 kg/m2, retinal disorders were reported by 6.9% of patients treated with WEGOVY (semaglutide 2.4 mg), 6.2% of patients treated with semaglutide 1 mg, and 4.2% of patients treated with placebo
At Prestige Medical Group, our Tirzepatide is compounded with BPC-157 peptide for enhanced tolerability and wellness support addressing the GI side effects commonly associated with GLP-1 and GLP-1/GIP medications
Designed for luxury and efficacy, each set can be customized to include a revitalizing cleanser, a high-potency serum, and a deep-nourishing moisture cream
Physician evaluation during intake will determine whether tirzepatide is appropriate for your specific situation
Dr Laura and her team are kind and professional, taking time to explain everything to you and throughout your treatment are continually checking in to ensure your comfort
